Clinical Experiences of Cardiac Myxoma

Department of Thoracic and Cardiovascular Surgery, Yonsei Cardiovascular Center, Yonsei University College of Medicine, Seodaemun-gu, Seoul 120-752, Korea.
Yonsei Medical Journal (Impact Factor: 1.26). 07/2006; 47(3):367-71. DOI: 10.3349/ymj.2006.47.3.367
Source: PubMed

ABSTRACT Although cardiac myxoma is rare, it is the most common primary cardiac tumor. Seventy-four cases of cardiac myxoma that were surgically treated in our center between August 1980 and February 2005 were retrospectively reviewed. The mean patient age was 50.4 +/- 15.0 (range 7-80) years, and 53 patients (71.6%) were female. The most common preoperative symptom, occurring in 44 patients, was dyspnea. The interval from onset of symptoms to surgery was 9 months. Seventy cases were located in the left atrium, 3 in the right atrium and 1 in the right ventricle. The myxoma in the right ventricle could not be resected completely, due to severe infiltration. Cardiopulmonary bypass and aortic cross clamp times were 100.4 +/- 37.1 and 64.8 +/- 29.8 minutes, respectively. There were no hospital deaths, and 7 patients suffered from postoperative complications including atrial fibrillation in 2 cases. During the follow up period (mean 105.7 +/- 73.6 months), there was no tumor recurrence and 6 late deaths that were not related to the underlying tumor. There was no evidence of tumor growth in the cases with incomplete resection during the 14-month follow-up. In conclusion, in this study there was no recurrence of tumors after complete resection and surgical resection is considered to be the curative method of treatment for cardiac myxoma.


Available from: Byung-Chul Chang, May 29, 2015
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: A rare possibility of occurring tumors in the heart is classified under two headings: primary cardiac tumors (that is originated in the heart tissues) and secondary cardiac tumors (which is metastasized to the heart). These tumors are mainly angiomas, sarcomas, myxomas, fibromas, lipomas and rhabdomyomas. Cardiac tumors are very rare with the incidence of about 0.0017 to 0.28%1,2. The main reason that can be attributed to such less susceptibility of heart for cancer is the less dividing nature of the cardiac myocytes. Any cell that is actively dividing is more likely to develop cancer which can be seen from the organs that are more prone to cancer for instance, skin, gastrointestinal tract, breast, cervices and many more. Cancer occurs when the cells start to disobey the laws of cell cycle progression. Thus, the cells divide rapidly surpassing the checkpoints which results in DNA damage or deleterious mutation. The more the cells divide, the higher the chances of mutation. Further, mutations occur more if the cells are dividing and replicating their DNAs abruptly. These mutations then pass on to the daughter cells and hence cause the cancer. In case of heart, the myocytes do not undergo cell division unless there is an injury and therefore very less cell division, the chances of mutation and cancer are less frequent. Moreover, our heart is also not directly exposed to carcinogens except for those in the circulating blood. This also leads to the decreased risk of mutations in the cardiac cells. Thus, owing to less cell division of cardiac cells, heart is at a less risk of developing cancer. In current review, we focused on different types of tumors in the heart and the cause of their rarity. Although less common, cardiac tumors affect a vital organ and hence the therapeutic perspectives should also be discussed.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: We report a case of myxoma with multiple recurrences in both the atrium and ventricle in a 26-year-old woman five years after the surgical removal of left atrial myxoma. Her 52-year-old mother had a similar medical history. To our knowledge, this was the first familial case who suffered multifocal cardiac myxoma recurrences without any sign of the myxoma complex. Based on our understanding of the mechanism of recurrence, the approaches to prevent the recurrence, and markers to predict recurrence, we propose that multifocal recurrences, as reported herein, may result from a combination of familial predisposition and multifocal onset. The bi-atrial surgical approach and transesophageal echocardiography are preferred for patients with recurrent cardiac myxomas, especially for those with multiple recurrences and familial myxoma. Immunological and genetic screenings may help to identify family members at risk for developing this disease.
    09/2011; 25(5):368-72. DOI:10.1016/S1674-8301(11)60049-3
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Myxoma of the aortic valve is an exceedingly uncommon condition. In this article, we report the case of a 72-year-old man with myxoma arising from the aortic valve. We extirpated the mass and repaired the aortic valve with the patient under cardiopulmonary bypass. The postoperative course was uneventful. Histological examination confirmed that the mass was a myxoma.
    Korean Circulation Journal 04/2012; 42(4):281-3. DOI:10.4070/kcj.2012.42.4.281